Francis Vekeman

Summary

Affiliation: Analysis Group
Country: USA

Publications

  1. ncbi Red blood cell transfusions and the risk of acute respiratory distress syndrome among the critically ill: a cohort study
    Marya D Zilberberg
    School of Public Health and Health Sciences, University of Massachusetts, Amherst, P, O, Box 303, Goshen, MA 01032, USA
    Crit Care 11:R63. 2007
  2. ncbi Healthcare costs associated with nephrology care in pre-dialysis chronic kidney disease patients
    Francis Vekeman
    Analysis Group, Inc, Washington, DC 20006, USA
    J Med Econ 13:673-80. 2010
  3. ncbi Relationship between hemoglobin level and quality of life in anemic patients with chronic kidney disease receiving epoetin alfa
    Patrick Lefebvre
    Groupe d Analyse, Ltee, Montreal, Quebec, Canada
    Curr Med Res Opin 22:1929-37. 2006
  4. ncbi Dose conversion and cost effectiveness of erythropoietic therapies in chemotherapy-related anemia: a Canadian application
    Pierre Cremieux
    Analysis Group, Inc, Boston, MA 02199, USA
    J Oncol Pharm Pract 12:165-78. 2006
  5. ncbi Dose and cost comparison of erythropoietic agents in the inpatient hospital setting
    Francis Vekeman
    Analysis Group, Inc, Montreal, Quebec, Canada
    Am J Health Syst Pharm 64:1943-9. 2007
  6. ncbi Risk of hepatotoxicity-related hospitalizations among patients treated with opioid/acetaminophen combination prescription pain medications
    Mei Sheng Duh
    Analysis Group, Inc, Boston, Massachusetts 02199, USA
    Pain Med 11:1718-25. 2010

Collaborators

Detail Information

Publications6

  1. ncbi Red blood cell transfusions and the risk of acute respiratory distress syndrome among the critically ill: a cohort study
    Marya D Zilberberg
    School of Public Health and Health Sciences, University of Massachusetts, Amherst, P, O, Box 303, Goshen, MA 01032, USA
    Crit Care 11:R63. 2007
    ..Uncertainty remains regarding the strength of this relationship...
  2. ncbi Healthcare costs associated with nephrology care in pre-dialysis chronic kidney disease patients
    Francis Vekeman
    Analysis Group, Inc, Washington, DC 20006, USA
    J Med Econ 13:673-80. 2010
    ..To compare the healthcare costs of pre-dialysis chronic kidney disease (CKD) patients cared for in a nephrology clinic setting versus other care settings...
  3. ncbi Relationship between hemoglobin level and quality of life in anemic patients with chronic kidney disease receiving epoetin alfa
    Patrick Lefebvre
    Groupe d Analyse, Ltee, Montreal, Quebec, Canada
    Curr Med Res Opin 22:1929-37. 2006
    ..To evaluate the relationship between hemoglobin (Hb) level and quality of life (QOL) in anemic patients with non-dialysis chronic kidney disease receiving epoetin alfa...
  4. ncbi Dose conversion and cost effectiveness of erythropoietic therapies in chemotherapy-related anemia: a Canadian application
    Pierre Cremieux
    Analysis Group, Inc, Boston, MA 02199, USA
    J Oncol Pharm Pract 12:165-78. 2006
    ..To determine the dose-conversion ratio (DCR) between epoetin alfa and darb-epoetin alfa in cancer patients and compare the treatment costs of both agents at the estimated DCRs...
  5. ncbi Dose and cost comparison of erythropoietic agents in the inpatient hospital setting
    Francis Vekeman
    Analysis Group, Inc, Montreal, Quebec, Canada
    Am J Health Syst Pharm 64:1943-9. 2007
    ..The inpatient dosing patterns and treatment costs in cancer and predialysis chronic kidney disease (CKD) patients treated with erythropoietic agents from a hospital pharmacy perspective were studied...
  6. ncbi Risk of hepatotoxicity-related hospitalizations among patients treated with opioid/acetaminophen combination prescription pain medications
    Mei Sheng Duh
    Analysis Group, Inc, Boston, Massachusetts 02199, USA
    Pain Med 11:1718-25. 2010
    ..This study determined the risk of serious hepatotoxicity resulting in hospitalizations among patients prescribed opioid/acetaminophen combinations...